DK1411917T3 - Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelser - Google Patents
Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelserInfo
- Publication number
- DK1411917T3 DK1411917T3 DK02714978T DK02714978T DK1411917T3 DK 1411917 T3 DK1411917 T3 DK 1411917T3 DK 02714978 T DK02714978 T DK 02714978T DK 02714978 T DK02714978 T DK 02714978T DK 1411917 T3 DK1411917 T3 DK 1411917T3
- Authority
- DK
- Denmark
- Prior art keywords
- prevention
- treatment
- movement disorders
- carbamate compounds
- carbamate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27168301P | 2001-02-27 | 2001-02-27 | |
| PCT/US2002/005542 WO2002067926A1 (en) | 2001-02-27 | 2002-02-21 | Carbamate compounds for use in preventing or treating movement disorders |
| US10/081,501 US6589985B2 (en) | 2001-02-27 | 2002-02-21 | Carbamate compounds for use in preventing or treating movement disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1411917T3 true DK1411917T3 (da) | 2007-09-24 |
Family
ID=26765643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02714978T DK1411917T3 (da) | 2001-02-27 | 2002-02-21 | Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelser |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6589985B2 (da) |
| EP (1) | EP1411917B1 (da) |
| JP (1) | JP2004527492A (da) |
| KR (1) | KR100858232B1 (da) |
| CN (1) | CN1262272C (da) |
| AR (1) | AR033426A1 (da) |
| AT (1) | ATE369130T1 (da) |
| AU (1) | AU2002247204B2 (da) |
| BR (1) | BR0207831A (da) |
| CA (1) | CA2439478C (da) |
| CY (1) | CY1106924T1 (da) |
| CZ (1) | CZ20032299A3 (da) |
| DE (1) | DE60221670T2 (da) |
| DK (1) | DK1411917T3 (da) |
| ES (1) | ES2291454T3 (da) |
| HK (1) | HK1067305A1 (da) |
| HU (1) | HUP0303344A3 (da) |
| IL (2) | IL157592A0 (da) |
| MX (1) | MXPA03007719A (da) |
| MY (1) | MY157373A (da) |
| NO (1) | NO20033803L (da) |
| NZ (1) | NZ551954A (da) |
| PL (1) | PL364679A1 (da) |
| PT (1) | PT1411917E (da) |
| RS (1) | RS50676B (da) |
| RU (1) | RU2294739C2 (da) |
| TW (1) | TWI331524B (da) |
| WO (1) | WO2002067926A1 (da) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0112713A (pt) * | 2000-07-21 | 2003-07-22 | Ortho Mcneil Pharm Inc | "compostos de carbamato para uso na prevenção ou tratamento de dor neuropática e dor associada a cefaléia em cacho e hemicrânia |
| CN1235579C (zh) * | 2001-02-27 | 2006-01-11 | 奥索-麦克尼尔药品公司 | 用于预防或治疗神经变性疾病的氨基甲酸酯化合物 |
| PT1408954E (pt) | 2001-07-16 | 2009-07-28 | Ortho Mcneil Janssen Pharm | Compostos carbamatos para utilização na prevenção ou tratamento da dor neuropática |
| WO2006133393A1 (en) | 2005-06-08 | 2006-12-14 | Sk Holdings Co., Ltd. | Treatment of sleep-wake disorders |
| PE20070325A1 (es) * | 2005-06-29 | 2007-05-12 | Alza Corp | Formas de dosificacion oral que comprenden compuestos derivados de carbamato |
| CN101272776B (zh) * | 2005-07-26 | 2012-10-03 | 詹森药业有限公司 | 氨基甲酸酯在制备治疗物质滥用相关疾病药物中的用途 |
| MX2009004798A (es) * | 2006-10-31 | 2009-08-12 | Janssen Pharmaceutica Nv | Tratamiento de los trastornos generalizados del desarrollo. |
| BR112012010648A2 (pt) | 2009-11-06 | 2020-12-01 | Sk Biopharmaceuticals Co., Ltd. | uso de compostos na preparação de composições farmacêuticas para tratar síndrome de fibromialgia e composição farmacêutica |
| MX2012005258A (es) | 2009-11-06 | 2012-06-19 | Sk Biopharmaceuticals Co Ltd | El uso de un compuesto de carbamoilo para el tratamiento del trastorno de deficit de atencion/hiperactividad. |
| US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
| US8623913B2 (en) * | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| KR101758543B1 (ko) | 2013-03-12 | 2017-07-14 | (주)바이오팜솔루션즈 | 페닐카바메이트 화합물 및 이를 포함하는 신경가스에 의한 질환의 예방 또는 치료용 조성물 |
| KR101717872B1 (ko) | 2013-03-12 | 2017-03-17 | (주)바이오팜솔루션즈 | 소아 간질 및 간질-관련 증후군의 예방 또는 치료용 페닐카바메이트 화합물 |
| CA3016253C (en) * | 2016-02-29 | 2020-12-29 | Bio-Pharm Solutions Co., Ltd. | Sulfamate derivative compounds, processes for preparing them and their uses |
| US10195151B2 (en) | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
| CA3046300A1 (en) * | 2016-12-14 | 2018-06-21 | Sk Biopharmaceuticals Co., Ltd. | Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndrome |
| KR20200016889A (ko) | 2017-06-02 | 2020-02-17 | 재즈 파마슈티칼즈 아일랜드 리미티드 | 과다 졸림증을 치료하기 위한 방법 및 조성물 |
| US10940133B1 (en) | 2020-03-19 | 2021-03-09 | Jazz Pharmaceuticals Ireland Limited | Methods of providing solriamfetol therapy to subjects with impaired renal function |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3313692A (en) | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
| US3265728A (en) | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
| US5698588A (en) | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
-
2002
- 2002-02-21 NZ NZ551954A patent/NZ551954A/en unknown
- 2002-02-21 EP EP02714978A patent/EP1411917B1/en not_active Expired - Lifetime
- 2002-02-21 HU HU0303344A patent/HUP0303344A3/hu unknown
- 2002-02-21 DE DE60221670T patent/DE60221670T2/de not_active Expired - Lifetime
- 2002-02-21 ES ES02714978T patent/ES2291454T3/es not_active Expired - Lifetime
- 2002-02-21 CA CA2439478A patent/CA2439478C/en not_active Expired - Fee Related
- 2002-02-21 AU AU2002247204A patent/AU2002247204B2/en not_active Ceased
- 2002-02-21 CZ CZ20032299A patent/CZ20032299A3/cs unknown
- 2002-02-21 DK DK02714978T patent/DK1411917T3/da active
- 2002-02-21 MX MXPA03007719A patent/MXPA03007719A/es active IP Right Grant
- 2002-02-21 BR BR0207831-7A patent/BR0207831A/pt not_active Application Discontinuation
- 2002-02-21 AT AT02714978T patent/ATE369130T1/de active
- 2002-02-21 JP JP2002567293A patent/JP2004527492A/ja active Pending
- 2002-02-21 KR KR1020037011271A patent/KR100858232B1/ko not_active IP Right Cessation
- 2002-02-21 US US10/081,501 patent/US6589985B2/en not_active Expired - Fee Related
- 2002-02-21 IL IL15759202A patent/IL157592A0/xx unknown
- 2002-02-21 RS YUP-677/03A patent/RS50676B/sr unknown
- 2002-02-21 PL PL02364679A patent/PL364679A1/xx not_active Application Discontinuation
- 2002-02-21 WO PCT/US2002/005542 patent/WO2002067926A1/en active IP Right Grant
- 2002-02-21 PT PT02714978T patent/PT1411917E/pt unknown
- 2002-02-21 CN CNB028089243A patent/CN1262272C/zh not_active Expired - Fee Related
- 2002-02-21 RU RU2003128985/14A patent/RU2294739C2/ru not_active IP Right Cessation
- 2002-02-27 MY MYPI20020692A patent/MY157373A/en unknown
- 2002-02-27 TW TW091103503A patent/TWI331524B/zh not_active IP Right Cessation
- 2002-02-27 AR ARP020100698A patent/AR033426A1/es unknown
-
2003
- 2003-08-26 NO NO20033803A patent/NO20033803L/no not_active Application Discontinuation
- 2003-08-26 IL IL157592A patent/IL157592A/en not_active IP Right Cessation
-
2004
- 2004-10-28 HK HK04108466A patent/HK1067305A1/xx not_active IP Right Cessation
-
2007
- 2007-10-10 CY CY20071101301T patent/CY1106924T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1411917T3 (da) | Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelser | |
| DK1427437T3 (da) | Oxyntomodulin til forebyggelse eller behandling af overvægt | |
| DK1446122T3 (da) | Anvendelse af flibanserin til behandling af uregelmæssigheder ved könsdriften | |
| IS7099A (is) | Efnasambönd til að meðhöndla bólgutruflanir | |
| DK1425001T3 (da) | Phenethanolaminderivater til behandling af respiratoriske sygdomme | |
| DK1562932T3 (da) | 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter | |
| DK1343773T3 (da) | Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser | |
| DK1420759T3 (da) | Farmaceutiske sammensætninger til behandling af astma | |
| DK1660057T3 (da) | Kombinationsterapi til behandling af neovaskulære øjenlidelser | |
| DK1063990T3 (da) | Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser | |
| DK1383489T3 (da) | Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af neurodegeneative sygdomme | |
| DK1448205T3 (da) | Kombinationer til behandling af immunoinflammatoriske sygdomme | |
| DK1499730T3 (da) | Immunokonjugater til behandling af tumorer | |
| DK1491212T3 (da) | Middel til behandling af søvnforstyrrelser | |
| DK1392318T3 (da) | 15-keto-prostaglandiner til behandling af lægemiddelinduceret forstoppelse | |
| ITMI20031311A0 (it) | Formulazioni per il trattamento di disturbi artrosici | |
| DK1694342T3 (da) | Fremgangsmåder til anvendelse af gelsolin til behandling eller forebyggelse af bakteriel sepsis | |
| DK1344526T3 (da) | Midler til forebyggelse/behandling af inflammatoriske luftvejslidelser | |
| NO20033804L (no) | Karbamatforbindelser for behandling av smerte | |
| DK1401424T3 (da) | Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af psykotiske forstyrrelser | |
| DK2845594T3 (da) | Anvendelse af dihydroimidazoloner til behandlingen af hunde. | |
| DK1268482T3 (da) | Pyranoindoler til behandling af glaukom | |
| DK1461042T3 (da) | Anvendelse af desoxypeganin til behandling af klinisk depression | |
| DK1390364T3 (da) | Aryl-8-azabicyclo[3.2.1]octaner til behandling af depression | |
| DK1468686T3 (da) | S-methyl-dihydro-ziprasidon til behandling af psykiatriske lidelser |